130
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Comparison of the quality of life and general health in opium and non-opium users referred to the addiction treatment centers

ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon & ORCID Icon
Pages 356-362 | Received 24 May 2020, Accepted 05 Oct 2020, Published online: 30 Oct 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Hamid Tavakoli Ghouchani, Hossein Lashkardoost, Alireza Afshari-Safavi, Faezeh Kaviyani, Mostafa Akbarzadeh, Zahra Yousefnejad & Hassan Saadati. (2023) Association between substance use treatment motivations and retention in treatment. Journal of Substance Use 0:0, pages 1-6.
Read now

Articles from other publishers (2)

Rohit GargAditi SinglaRajnish Raj. (2023) Health-related quality of life and stigma in opioid dependence: Comparison between buprenorphine users and non-users. Journal of Neurosciences in Rural Practice 14, pages 453-458.
Crossref
Hamid Tavakoli Ghouchani, Hossein Lashkardoost, Hassan Saadati, Seyed Kaveh Hojjat, Faezeh Kaviyani, Kazem Razaghi, Dordane Asghari & Nazanin Gholizadeh. (2021) Developing and validating a measurement tool to self-report perceived barriers in substance use treatment: the substance use treatment barriers questionnaire (SUTBQ). Substance Abuse Treatment, Prevention, and Policy 16:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.